Cite
HARVARD Citation
Wang, H. et al. (2019). In silico simulation of a clinical trial with anti-CTLA-4 and anti-PD-L1 immunotherapies in metastatic breast cancer using a systems pharmacology model. Royal Society open science. 6 (5), p. . [Online].